T-448
CAS No. 1597426-53-3
T-448( T448 | T 448 )
Catalog No. M12284 CAS No. 1597426-53-3
T-448 (T448) is a specific inhibitor of LSD1 enzyme activity, enhances H3K4 methylation in primary cultured rat neurons but has little impact on LSD1-GFI1B complex in human TF-1a erythroblasts.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 770 | In Stock |
|
| 10MG | 1169 | In Stock |
|
| 25MG | 1929 | In Stock |
|
| 50MG | 2651 | In Stock |
|
| 100MG | 3562 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameT-448
-
NoteResearch use only, not for human use.
-
Brief DescriptionT-448 (T448) is a specific inhibitor of LSD1 enzyme activity, enhances H3K4 methylation in primary cultured rat neurons but has little impact on LSD1-GFI1B complex in human TF-1a erythroblasts.
-
DescriptionT-448 (T448) is a specific inhibitor of LSD1 enzyme activity, enhances H3K4 methylation in primary cultured rat neurons but has little impact on LSD1-GFI1B complex in human TF-1a erythroblasts; increases brain H3K4 methylation and partially restored learning function in mice with NMDA receptor hypofunction, shows unique therapeutic approaches for central nervous system disorders associated with epigenetic dysregulation.
-
In VitroT-448 enhances the levels of H3K4 methylation, increased mRNA expression of neural plasticity-related genes including brain derived neurotrophic factor (Bdnf), and ameliorated learning dysfunction. RT-PCR.Cell Line:Primary cultured rat neurons. Concentration:0-10 μM.Incubation Time:1 day treatment.Result:Increased Ucp2 H3K4me2 and Ucp2 mRNA significantly.
-
In VivoT-448 has minimal impact on the LSD1-GFI1B complex and a superior hematological safety profile in mice via the generation of a compact formyl-FAD adduct. T-448 increases brain H3K4 methylation and partially restored learning function in mice with NMDA receptor hypofunction.T-448 increases H3K4 methylation in the brain without causing hematological side effects even at 100 mg/kg. Animal Model:NR1-hypo mice.Dosage:1, 10 mg/kg.Administration:Orally, 3 weeks.Result:Dose-dependently increased the H3K4me2 levels around Bdnf, Arc, and Fos genes in the mouse hippocampus. Resulted in partial but statistically significant and dosedependent rescue effects on the rate of correct choices in NR1-hypo mice.
-
SynonymsT448 | T 448
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorHistone Demethylase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1597426-53-3
-
Formula Weight444.506
-
Molecular FormulaC21H24N4O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 16.67 mg/mL (43.13 mM)
-
SMILESCC1=NN=C(S1)NC(=O)C2=CC=CC(=C2)C3CC3NC4CCC4.C(=CC(=O)O)C(=O)O
-
Chemical Name3-((1S,2R)-2-(cyclobutylamino)cyclopropyl)-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzamide fumarate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Matsuda S, et al. Neuropsychopharmacology. 2018 Dec 22. doi: 10.1038/s41386-018-0300-9.
molnova catalog
related products
-
GSK J5
GSK J5 is an inhibitor of schistosomes and helminths and is often used as a trematode insecticide.GSK J5 promotes schistosome mortality in a dose- and time-dependent manner.
-
KDM4D-IN-10r
KDM4D-IN-10r is a potent, selective histone lysine demethylase 4D (KDM4D) inhibitor with IC50 of 0.41 uM.
-
KDM5-C49
KDM5-C49 is a potent, selective KDM5 inhibitor with IC50 of 25, 30 and 59 nM for KDM5A, B and C, respectively.
Cart
sales@molnova.com